COMPASS Pathways (CMPS) News Today $3.02 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$3.00 -0.02 (-0.70%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Argenx Se (ARGX) and COMPASS Pathways (CMPS)April 11, 2025 | markets.businessinsider.comMorgan Stanley Remains a Buy on COMPASS Pathways (CMPS)April 3, 2025 | markets.businessinsider.comCOMPASS Pathways plc (NASDAQ:CMPS) Given Average Rating of "Buy" by BrokeragesShares of COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) have been given an average recommendation of "Buy" by the seven research firms that are presently covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 yearMarch 31, 2025 | marketbeat.comCOMPASS Pathways' (CMPS) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of COMPASS Pathways in a research report on Friday.March 29, 2025 | marketbeat.comThis Is a Test From GlobeNewswireMarch 28, 2025 | globenewswire.comBIT Capital GmbH Purchases New Shares in COMPASS Pathways plc (NASDAQ:CMPS)BIT Capital GmbH purchased a new position in shares of COMPASS Pathways plc (NASDAQ:CMPS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 115,697 shares of the company's stock,March 28, 2025 | marketbeat.comCompass Pathways announces published study on psilocybin in depressionMarch 18, 2025 | markets.businessinsider.comCOMPASS Pathways plc (NASDAQ:CMPS) Shares Acquired by Brown UniversityBrown University grew its stake in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 194.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 214,200 shares of the company's stock after purchasing an additMarch 17, 2025 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Short Interest UpdateCOMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 5,440,000 shares, an increase of 21.7% from the January 31st total of 4,470,000 shares. Based on an average trading volume of 1,020,000 shares, the short-interest ratio is presently 5.3 days.March 7, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for COMPASS Pathways (NASDAQ:CMPS)HC Wainwright reaffirmed a "buy" rating and set a $45.00 target price on shares of COMPASS Pathways in a research note on Tuesday.March 5, 2025 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Given Average Recommendation of "Buy" by BrokeragesShares of COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) have been given an average rating of "Buy" by the seven brokerages that are covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 1-year price target amMarch 5, 2025 | marketbeat.comCompass one of the most compelling stories in neuropsych, says H.C. WainwrightMarch 4, 2025 | msn.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and COMPASS Pathways (CMPS)March 3, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Rani Therapeutics Holdings (RANI)March 1, 2025 | markets.businessinsider.comCOMPASS Pathways plc (CMPS): Among the Best Psychedelic Stocks to Buy in 2025March 1, 2025 | msn.comCOMPASS Pathways (NASDAQ:CMPS) Price Target Lowered to $15.00 at Canaccord Genuity GroupCanaccord Genuity Group lowered their price objective on COMPASS Pathways from $23.00 to $15.00 and set a "buy" rating for the company in a research report on Friday.March 1, 2025 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Releases Earnings Results, Misses Expectations By $0.01 EPSCOMPASS Pathways (NASDAQ:CMPS - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.62) by ($0.01).February 28, 2025 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPSCOMPASS Pathways (NASDAQ:CMPS - Get Free Report) announced its earnings results on Thursday. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.62) by ($0.01).February 28, 2025 | marketbeat.comCompass Pathways PLC (CMPS) Q4 2024 Earnings Call Highlights: Strategic Financing and R&D ...February 28, 2025 | finance.yahoo.comStifel Initiates Coverage of COMPASS Pathways plc - Depositary Receipt () (CMPS) with Buy RecommendationFebruary 28, 2025 | msn.comCompass Pathways sees FY25 net cash use $120M-$145MFebruary 27, 2025 | markets.businessinsider.comCompass Pathways rises 10% as Stifel initiates with a buyFebruary 27, 2025 | msn.comPsychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst SaysFebruary 27, 2025 | benzinga.comCOMPASS Pathways plc (CMPS) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comCOMPASS Pathways (NASDAQ:CMPS) Earns Buy Rating from Analysts at Stifel NicolausStifel Nicolaus assumed coverage on COMPASS Pathways in a research report on Thursday. They issued a "buy" rating and a $11.00 target price on the stock.February 27, 2025 | marketbeat.comCompass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business HighlightsFebruary 27, 2025 | businesswire.comCompass Pathways initiated with a Buy at StifelFebruary 27, 2025 | markets.businessinsider.comARK Investment Management LLC Has $6.56 Million Stock Position in COMPASS Pathways plc (NASDAQ:CMPS)ARK Investment Management LLC lowered its stake in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) by 13.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,736,202 shares of the company's stock after selling 268,923 shares durinFebruary 26, 2025 | marketbeat.comCompass Pathways to Participate in TD Cowen 45th Annual Health Care ConferenceFebruary 25, 2025 | businesswire.comCOMPASS Pathways (CMPS) Projected to Post Quarterly Earnings on ThursdayCOMPASS Pathways (NASDAQ:CMPS) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=667180)February 25, 2025 | marketbeat.comCOMPASS Pathways (CMPS) Projected to Post Earnings on ThursdayCOMPASS Pathways (NASDAQ:CMPS) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=667180)February 21, 2025 | marketbeat.comCompass Pathways to announce fourth quarter and year-end financial results on February 27 th, 2025February 19, 2025 | businesswire.comCompass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025February 18, 2025 | businesswire.comHC Wainwright Expects Higher Earnings for COMPASS PathwaysCOMPASS Pathways plc (NASDAQ:CMPS - Free Report) - HC Wainwright upped their Q1 2025 EPS estimates for COMPASS Pathways in a research note issued on Thursday, February 13th. HC Wainwright analyst P. Trucchio now forecasts that the company will post earnings per share of ($0.34) for the quarter, uFebruary 17, 2025 | marketbeat.comFY2028 EPS Forecast for COMPASS Pathways Lowered by AnalystCOMPASS Pathways plc (NASDAQ:CMPS - Free Report) - Research analysts at HC Wainwright decreased their FY2028 EPS estimates for COMPASS Pathways in a research note issued on Thursday, February 13th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share ofFebruary 15, 2025 | marketbeat.comCompass Pathways price target lowered to $45 from $60 at H.C. WainwrightFebruary 14, 2025 | markets.businessinsider.comH.C. Wainwright cuts Compass Pathways stock target to $45February 13, 2025 | msn.comCOMPASS Pathways (NASDAQ:CMPS) Price Target Lowered to $45.00 at HC WainwrightHC Wainwright lowered their price objective on shares of COMPASS Pathways from $60.00 to $45.00 and set a "buy" rating on the stock in a report on Thursday.February 13, 2025 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Receives $33.60 Average Price Target from AnalystsShares of COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) have received a consensus rating of "Buy" from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month taFebruary 11, 2025 | marketbeat.comCOMPASS Pathways plc (NASDAQ:CMPS) Receives Consensus Rating of "Buy" from AnalystsShares of COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) have received a consensus recommendation of "Buy" from the six ratings firms that are covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month prFebruary 8, 2025 | marketbeat.comCompass Pathways plc: Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 5, 2025 | finanznachrichten.deCompass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 5, 2025 | finance.yahoo.comH.C. Wainwright Remains a Buy on COMPASS Pathways (CMPS)February 5, 2025 | markets.businessinsider.comRodman cuts Compass Pathways stock target to $9, maintains BuyJanuary 27, 2025 | msn.comCantor Fitzgerald Weighs in on CMPS FY2025 EarningsCOMPASS Pathways plc (NASDAQ:CMPS - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for COMPASS Pathways in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst C. Duncan anticipates that the company will earn ($2.05) per share for the year. ThJanuary 23, 2025 | marketbeat.comCantor Fitzgerald Forecasts CMPS FY2025 EarningsCOMPASS Pathways plc (NASDAQ:CMPS - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings estimates for COMPASS Pathways in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst C. Duncan anticipates that the company will post earnings of (January 22, 2025 | marketbeat.comCompass Pathways appoints Steve Levine as Chief Patient OfficerJanuary 21, 2025 | markets.businessinsider.comCompass Pathways Appoints Steve Levine, M.D., as Chief Patient OfficerJanuary 21, 2025 | businesswire.comAnalysts Set COMPASS Pathways plc (NASDAQ:CMPS) PT at $33.60COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) has been given an average rating of "Buy" by the six analysts that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among analysJanuary 17, 2025 | marketbeat.comCOMPASS Pathways (NASDAQ:CMPS) Given "Outperform" Rating at Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and issued a $18.00 price objective on shares of COMPASS Pathways in a research report on Wednesday.January 16, 2025 | marketbeat.com Remove Ads Get COMPASS Pathways News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Email Address CMPS Media Mentions By Week CMPS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMPS News Sentiment▼0.940.80▲Average Medical News Sentiment CMPS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMPS Articles This Week▼22▲CMPS Articles Average Week Remove Ads Get COMPASS Pathways News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARDX News Today GPCR News Today AUPH News Today SNDX News Today WVE News Today MLYS News Today ETNB News Today COLL News Today ELVN News Today DYN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMPS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding COMPASS Pathways plc Please log in to your account or sign up in order to add this asset to your watchlist. Share COMPASS Pathways With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMPS Stock Free CMPS Stock Alerts